Novartis claims Takeda is stonewalling efforts to review trade secrets taken by a former employee

This case was subsequently dismissed by Novartis.

Novartis has gone to court to gain access to Takeda Pharmaceutical documents over concerns that a former employee took trade secrets with him to his new job at the rival drugmaker.

In a complaint filed in Massachusetts Superior Court, Novartis claimed that Khaled Shams Eldin transferred approximately 10,000 company files to his personal e-mail before leaving his job last May in Cairo, where he most recently worked in technical operations handling site divestments and relationships with suppliers, according to his LinkedIn page.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In